The FDA has approved GlaxoSmithKline’s Jemperli (dostarlimab) immunotherapy ... which are being investigated in the phase 1 GARNET open-label basket trial, where a first part tested dostarlimab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback